Originally derived from gastric proteins, BPC-157 works systemically to promote blood flow, tissue repair, and cellular regenerationmaking it highly valuable for patients dealing with injuries, chronic inflammation, gastrointestinal dysfunction, or delayed recovery
The pushback had a familiar flavour: You havent proved it doesnt work, and lack of human data doesnt mean lack of benefit. And "It's got a plausible mechanism." Heres my issue If you are going to claim efficacy (healing, belly fat loss, GH boosting, hypertrophy), you should be able to back that up with human trials for that claim, at that dose, with a defined product
These unique structural features, particularly the way it engages with the receptors, are proposed to contribute to its potent and long-acting clinical efficacy as a dual agonist for weight management
Pharmacokinetics, metabolism, distribution and permeability of nanomedicine
[DOI] [PMC free article] [PubMed] [Google Scholar] 131.Govindan R
As with any research compound, appropriate caution, informed consent, and medical supervision are essential
